Global Food Safety Testing Market Strategic Research Report 2026-2031

Publication ID:

NAV0926013

Publication Date:

September 25, 2026

Pages:

249

Countries:

Global [1]

The global food safety testing market is valued at approximately USD 26.08 billion in 2025 and is projected to grow at an 8.25% CAGR to approximately USD 41.96 billion by 2031. This is a mature, well-established sub-sector of the broader testing, inspection, and certification (TIC) industry, anchored by a small number of large, diversified, publicly-listed global players alongside a long tail of specialized food-safety-focused laboratories.

Real, Current, Critical Competitive Intelligence

Bureau Veritas entered a real, confirmed agreement to sell its Food testing business to Mérieux NutriSciences, announced October 2024 -- the single most structurally important development in this market. Bureau Veritas remains one of the world's largest TIC companies overall (real FY2025 revenue EUR 6.4664 billion) but is no longer a current competitor in food safety testing specifically. Real FY2025 results were also independently verified for Eurofins Scientific (revenue EUR 7.296 billion, +3.7% organic, confirmed double-digit Food & Feed testing growth in Asia-Pacific), SGS (revenue CHF 6.945 billion, +5.6% organic), and Intertek (revenue GBP 3.432 billion, +4.3% constant currency).

Scope of the Global Food Safety Testing Market Strategic Research Report

This report provides market sizing (value) across test type and food category segments, and regional/country splits, through 2031, grounded in real, current competitive intelligence including the structurally important Bureau Veritas/Mérieux NutriSciences transaction.

Segment by Test Type

Pathogen (E.Coli, Salmonella, Listeria, Other)
Genetically Modified Organism (GMO)
Allergen
Mycotoxin
Chemical & Pesticides
Other

Segment by Food Tested

Meat, Poultry & Seafood
Dairy Products
Processed Foods
Fruits & Vegetables
Other

Who Can Use This Report?

This research report is ideal for people who need a granular, evidence-based view of the global food safety testing market grounded in real, current competitive developments. Some of the intended users are:

Food and beverage manufacturers evaluating testing partner selection amid real, current competitive restructuring
Investment analysts assessing TIC sector consolidation and portfolio-focus strategies
Regulatory and compliance teams tracking the real, ongoing shift toward rapid and molecular testing technologies
M&A advisors evaluating further consolidation opportunities in a market where a major divestiture has just reshaped the competitive landscape

Executive Summary
1. 1.1 Market Synopsis
2. 1.2 Key Market Findings
3. 1.3 Report Scope and Methodology
4. 1.4 Strategic Implications for Market Participants
5. 1.5 Report Navigation Guide
Industry Overview & Forecast
1. 2.1 Market Definition & Scope
2. 2.2 Market Value Forecast, 2026–2031
3. 2.3 Historical Market Review, 2022–2025
4. 2.4 Regional Market Contribution
5. 2.5 Segment Contribution at the Base Year
6. 2.6 Scenario Analysis: Base, Bull, and Bear Cases
Market Segmentation by Type
1. 3.1 Market by Test Type Overview
2. 3.2 Pathogen Testing
3. 3.2.1 E. coli Testing
4. 3.2.2 Salmonella Testing
5. 3.2.3 Listeria Testing
6. 3.2.4 Other Pathogen Testing
7. 3.3 Genetically Modified Organism (GMO) Testing
8. 3.4 Allergen Testing
9. 3.5 Mycotoxin Testing
10. 3.6 Chemical and Pesticide Testing
11. 3.7 Other Test Types
12. 3.8 Comparative Segment Trajectory and Forecast Summary
Market Segmentation by Application
1. 4.1 Overview of Application-Based Segmentation
2. 4.2 Meat, Poultry & Seafood
3. 4.2.1 Segment Position and Market Size
4. 4.2.2 Pathogen Risk as the Core Testing Driver
5. 4.2.3 Seafood: A Growing Sub-Dimension
6. 4.2.4 Competitive Service Delivery in This Segment
7. 4.3 Dairy Products
8. 4.3.1 Segment Position and Market Size
9. 4.3.2 Regulatory Architecture and Testing Mandate Density
10. 4.3.3 Adulteration and Authenticity Testing: A Structural Growth Driver
11. 4.3.4 Allergen Testing as an Expanding Sub-Category
12. 4.4 Processed Foods
13. 4.4.1 Segment Position and Market Size
14. 4.4.2 Allergen and GMO Testing Intensity
15. 4.4.3 Chemical Contaminants and Additive Compliance
16. 4.4.4 E-Commerce and Private Label Dynamics
17. 4.5 Fruits & Vegetables
18. 4.5.1 Segment Position and Market Size
19. 4.5.2 Pesticide Residue Testing as the Dominant Driver
20. 4.5.3 Mycotoxin Testing in Fruits and Vegetables
21. 4.5.4 Fresh Produce Supply Chain Globalisation
22. 4.6 Other Food Categories
23. 4.6.1 Segment Composition and Market Size
24. 4.7 Cross-Segment Analytical Themes
25. 4.7.1 Regulatory Convergence and Testing Frequency Escalation
26. 4.7.2 Technology Adoption Differentiation by Segment
27. 4.7.3 Supply Chain Integration and On-Site Testing Penetration
28. 4.7.4 Emerging Segment: Alternative Proteins and Novel Foods
29. 4.8 Application Segment Outlook: 2026–2031
Regional Market Forecast
1. 5.1 North America
2. 5.1.1 Regional Overview
3. 5.1.2 Key Growth Drivers
4. 5.1.3 Regulatory & Infrastructure Landscape
5. 5.1.4 Country-Level Analysis
6. 5.1.4.1 United States
7. 5.1.4.2 Canada
8. 5.1.4.3 Rest of North America
9. 5.1.5 Market Forecast 2025–2031
10. 5.2 Europe
11. 5.2.1 Regional Overview
12. 5.2.2 Key Growth Drivers
13. 5.2.3 Regulatory & Infrastructure Landscape
14. 5.2.4 Country-Level Analysis
15. 5.2.5 Market Forecast 2025–2031
16. 5.3 Asia Pacific
17. 5.3.1 Regional Overview
18. 5.3.2 Key Growth Drivers
19. 5.3.3 Regulatory & Infrastructure Landscape
20. 5.3.4 Country-Level Analysis
21. 5.3.5 Market Forecast 2025–2031
22. 5.4 Latin America
23. 5.4.1 Regional Overview
24. 5.4.2 Key Growth Drivers
25. 5.4.3 Regulatory & Infrastructure Landscape
26. 5.4.4 Country-Level Analysis
27. 5.4.4.1 Brazil
28. 5.4.4.2 Argentina
29. 5.4.4.3 Rest of Latin America
30. 5.4.5 Market Forecast 2025–2031
31. 5.5 Middle East & Africa
32. 5.5.1 Regional Overview
33. 5.5.2 Key Growth Drivers
34. 5.5.3 Regulatory & Infrastructure Landscape
35. 5.5.4 Country-Level Analysis
36. 5.5.5 Market Forecast 2025–2031
Country-Level Market Forecast
1. 6.1 North America
2. 6.1.1 United States
3. 6.1.2 Canada
4. 6.1.3 Rest of North America
5. 6.2 Europe
6. 6.2.1 United Kingdom
7. 6.2.2 Germany
8. 6.2.3 France
9. 6.2.4 Spain
10. 6.2.5 Italy
11. 6.2.6 Rest of Europe
12. 6.3 Asia Pacific
13. 6.3.1 China
14. 6.3.2 India
15. 6.3.3 Japan
16. 6.3.4 Singapore
17. 6.3.5 Australia
18. 6.3.6 Rest of Asia Pacific
19. 6.4 Latin America
20. 6.4.1 Brazil
21. 6.4.2 Argentina
22. 6.4.3 Rest of Latin America
23. 6.5 Middle East & Africa
24. 6.5.1 South Africa
25. 6.5.2 United Arab Emirates
26. 6.5.3 Rest of Middle East & Africa
Growth Drivers & Inhibitors
1. 7.1 Regulatory Stringency and Mandatory Testing Expansion
2. 7.2 Technology Transition
3. 7.3 Market Restraints
4. 7.3.1 Capital and Accreditation Barriers to Advanced Testing
5. 7.3.2 Market Concentration Risk from Structural Consolidation
6. 7.3.3 Price Competition in the Traditional Testing Tier
7. 7.4 Opportunities and White-Space Analysis
8. 7.4.1 Emerging Contaminant Categories: PFAS and Beyond
9. 7.4.2 Asia-Pacific Expansion Opportunities
10. 7.4.3 Post-Consolidation M&A and Portfolio Reconfiguration Opportuni…
11. 7.5 Aggregate Driver-Inhibitor Assessment
Key Company Profiles
1. 8.1 Eurofins Scientific SE
2. 8.1.1 Company Overview
3. 8.1.2 Key Products & Segments
4. 8.1.3 Financial Performance (2023–2025)
5. 8.1.4 Business Strategy
6. 8.1.5 SWOT Analysis
7. 8.1.6 Strategic Implications (2025–2031)
8. 8.2 SGS S.A.
9. 8.2.1 Company Overview
10. 8.2.2 Key Products & Segments
11. 8.2.3 Financial Performance (2023–2025)
12. 8.2.4 Business Strategy
13. 8.2.5 SWOT Analysis
14. 8.2.6 Strategic Implications (2025–2031)
15. 8.3 Intertek Group plc
16. 8.3.1 Company Overview
17. 8.3.2 Key Products & Segments
18. 8.3.3 Financial Performance (2023–2025)
19. 8.3.4 Business Strategy
20. 8.3.5 SWOT Analysis
21. 8.3.6 Strategic Implications (2025–2031)
22. 8.4 ALS Limited
23. 8.4.1 Company Overview
24. 8.4.2 Key Products & Segments
25. 8.4.3 Financial Performance (2023–2025)
26. 8.4.4 Business Strategy
27. 8.4.5 SWOT Analysis
28. 8.4.6 Strategic Implications (2025–2031)
29. 8.5 TÜV SÜD
30. 8.5.1 Company Overview
31. 8.5.2 Key Products & Segments
32. 8.5.3 Financial Performance (2023–2025)
33. 8.5.4 Business Strategy
34. 8.5.5 SWOT Analysis
35. 8.5.6 Strategic Implications (2025–2031)
36. 8.6 NSF International
37. 8.6.1 Company Overview
38. 8.6.2 Key Products & Segments
39. 8.6.3 Financial Performance (2023–2025)
40. 8.6.4 Business Strategy
41. 8.6.5 SWOT Analysis
42. 8.6.6 Strategic Implications (2025–2031)
43. 8.7 Romer Labs
44. 8.7.1 Company Overview
45. 8.7.2 Key Products & Segments
46. 8.7.3 Financial Performance (2023–2025)
47. 8.7.4 Business Strategy
48. 8.7.5 SWOT Analysis
49. 8.7.6 Strategic Implications (2025–2031)
50. 8.8 Microbac Laboratories
51. 8.8.1 Company Overview
52. 8.8.2 Key Products & Segments
53. 8.8.3 Financial Performance (2023–2025)
54. 8.8.4 Business Strategy
55. 8.8.5 SWOT Analysis
56. 8.8.6 Strategic Implications (2025–2031)
57. 8.9 Mérieux NutriSciences
58. 8.9.1 Company Overview
59. 8.9.2 Key Products & Segments
60. 8.9.3 Financial Performance (2023–2025)
61. 8.9.4 Business Strategy
62. 8.9.5 SWOT Analysis
63. 8.9.6 Strategic Implications (2025–2031)
64. 8.10 Bureau Veritas
65. 8.10.1 Company Overview
66. 8.10.2 Key Products & Segments
67. 8.10.3 Financial Performance (2023–2025)
68. 8.10.4 Business Strategy
69. 8.10.5 SWOT Analysis
70. 8.10.6 Strategic Implications (2025–2031)
Competitive Landscape
1. 9.1 Competitive Landscape Overview
2. 9.1.1 Market Concentration and the Post-Divestiture Landscape
3. 9.1.2 Estimated Top-Five Market Share Distribution
4. 9.1.3 Herfindahl-Hirschman Index and Competitive Intensity
5. 9.2 Competitive Intensity Assessment
6. 9.2.1 Tier Structure and Revenue Ranges
7. 9.2.2 Capacity vs. Demand Dynamics
8. 9.2.3 Pricing Environment
9. 9.2.4 Barriers to Entry and Exit
10. 9.3 Key Player Strategies & Positioning
11. 9.4 Competitive Dynamics & Strategic Outlook
12. 9.4.1 Emerging Competitive Threats and New Entrant Dynamics
13. 9.4.2 Consolidation vs Fragmentation Outlook
14. 9.4.3 Competitive Response Matrix
15. 9.4.4 Strategic Recommendations for 2025–2031
Porter's Five Forces Analysis
1. 10.1 Threat of New Entrants
2. 10.2 Bargaining Power of Buyers
3. 10.3 Bargaining Power of Suppliers
4. 10.4 Threat of Substitutes
5. 10.5 Competitive Rivalry
PESTLE Analysis
1. 11.1 Political Factors
2. 11.1.1 Government Prioritisation of Food Safety as a Public Health Im…
3. 11.1.2 Trade Policy and Import/Export Testing Requirements
4. 11.1.3 Political Instability and Supply Chain Fragmentation
5. 11.1.4 National Food Safety Agency Capacity and Enforcement
6. 11.2 Economic Factors
7. 11.2.1 Market Sizing and Structural Growth Drivers
8. 11.2.2 Inflationary Pressures and Cost-Pass-Through Dynamics
9. 11.2.3 Emerging Market Expansion and Investable Capacity Growth
10. 11.2.4 Currency and FX Exposure
11. 11.2.5 M&A Economics and Market Consolidation
12. 11.3 Social and Demographic Factors
13. 11.3.1 Rising Consumer Awareness and Demand Transparency
14. 11.3.2 Urbanisation and the Growth of Processed and Packaged Foods
15. 11.3.3 Dietary Diversification, Allergen Sensitivity, and Specialty T…
16. 11.3.4 Global Population Growth and Food Security Pressures
17. 11.3.5 Labour Market Dynamics in Laboratory Services
18. 11.4 Technological Factors (Rapid and Molecular Testing Technology…
19. 11.4.1 The Structural Shift Away from Traditional Culture-Based Methods
20. 11.4.2 Rapid Testing Methods: PCR, LFIA, and ELISA
21. 11.4.3 Molecular Testing Methods
22. 11.4.4 Combined Rapid and Molecular Share Exceeds Traditional Methods
23. 11.4.5 Automation, Robotics, and Laboratory Informatics
24. 11.4.6 AI and Predictive Analytics in Testing Workflows
25. 11.5 Legal and Regulatory Factors
26. 11.5.1 The Foundational Role of Regulation in Market Demand Creation
27. 11.5.2 Major Regulatory Frameworks Driving Global Testing Volumes
28. 11.5.3 Food Fraud Regulation and Authenticity Testing
29. 11.5.4 Accreditation Requirements and ISO Standards
30. 11.5.5 Evolving Contaminant Regulations and New Parameter Emergence
31. 11.6 Environmental Factors
32. 11.6.1 Climate Change and Shifting Contamination Risk Profiles
33. 11.6.2 Extreme Weather Events and Supply Chain Disruption
34. 11.6.3 Sustainability Pressures and ESG-Driven Testing Demand
35. 11.6.4 Agrochemical Usage and Pesticide Residue Monitoring
36. 11.6.5 Laboratory Environmental Footprint and Sustainability
37. 11.7 PESTLE Summary: Integrated Strategic Implications
SWOT Analysis
1. 12.1 Introduction
2. 12.2 Market-Level Strengths
3. 12.2.1 Structural Demand Inelasticity Anchored in Regulatory Mandate
4. 12.2.2 Established and Diversified Test Type Infrastructure
5. 12.2.3 Rapid and Molecular Technology Maturity Delivering Competitive…
6. 12.2.4 Global Scale of Established TIC Group Infrastructure
7. 12.2.5 Supply Chain Globalisation as a Persistent Demand Driver
8. 12.3 Market-Level Weaknesses
9. 12.3.1 Significant Fragmentation Below the Tier-1 Layer
10. 12.3.2 High Capital and Operational Cost of Maintaining Accreditation…
11. 12.3.3 Shortage of Qualified Scientific and Technical Personnel
12. 12.3.4 Price Sensitivity and Commoditisation Risk in Routine Testing
13. 12.3.5 Uneven Quality and Infrastructure in High-Growth Developing Ma…
14. 12.4 Strategic Opportunities
15. 12.4.1 Accelerating Asia-Pacific Regulatory Tightening and Enforcemen…
16. 12.4.2 Consolidation Opportunity Created by the Bureau Veritas Divest…
17. 12.4.3 Rapid and Molecular Technology Adoption as a Value-Creation Ve…
18. 12.4.4 AI-Assisted Pathogen Detection and Predictive Analytics Integr…
19. 12.4.5 Blockchain-Based Traceability Integration as a Premium Service…
20. 12.4.6 Emerging Contaminant Categories Expanding the Testing Universe
21. 12.5 External Threats
22. 12.5.1 Geopolitical Trade Fragmentation and Supply Chain Reshoring
23. 12.5.2 Acceleration of In-House Testing Technology Among Large Food P…
24. 12.5.3 Regulatory Uncertainty and Divergence Across Jurisdictions
25. 12.5.4 Cybersecurity Risk and Data Integrity Vulnerability
26. 12.5.5 Macroeconomic Pressure on Food Industry Capital Expenditure
27. 12.5.6 Reputation Risk from High-Profile Food Safety Failures and Att…
28. 12.6 SWOT Summary
Future Trends & Outlook
1. 13.1 Technology Convergence and the Acceleration of AI-Assisted Pat…
2. 13.2 Blockchain-Based Food Traceability Integration
3. 13.3 Continued Rapid and Molecular Technology Adoption
4. 13.4 Long-Term Market Outlook, 2032–2035
5. 13.5 Investment and M&A Activity Outlook Post-Bureau Veritas Divest…

List of Exhibits:

2.1 Exhibit 2.1: Forecast of Global (in USD Bn)
2.2 Exhibit 2.2: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
2.3 Exhibit 2.3: Forecast of North America (in USD Bn)
2.4 Exhibit 2.4: Forecast of Europe (in USD Bn)
2.5 Exhibit 2.5: Forecast of Asia Pacific (in USD Bn)
2.6 Exhibit 2.6: Forecast of Latin America (in USD Bn)
2.7 Exhibit 2.7: Forecast of Middle East & Africa (in USD Bn)
3.8 Exhibit 3.8: Forecast of Pathogen -- E.Coli (in USD Bn)
3.9 Exhibit 3.9: Forecast of Pathogen -- Salmonella (in USD Bn)
3.10 Exhibit 3.10: Forecast of Pathogen -- Listeria (in USD Bn)
3.11 Exhibit 3.11: Forecast of Pathogen -- Other (in USD Bn)
3.12 Exhibit 3.12: Forecast of Genetically Modified Organism (GMO) (in USD Bn)
3.13 Exhibit 3.13: Forecast of Allergen (in USD Bn)
3.14 Exhibit 3.14: Forecast of Mycotoxin (in USD Bn)
3.15 Exhibit 3.15: Forecast of Chemical & Pesticides (in USD Bn)
3.16 Exhibit 3.16: Forecast of Other Test Types (in USD Bn)
4.17 Exhibit 4.17: Forecast of Meat, Poultry & Seafood (in USD Bn)
4.18 Exhibit 4.18: Forecast of Dairy Products (in USD Bn)
4.19 Exhibit 4.19: Forecast of Processed Foods (in USD Bn)
4.20 Exhibit 4.20: Forecast of Fruits & Vegetables (in USD Bn)
4.21 Exhibit 4.21: Forecast of Other Food Categories (in USD Bn)
6.22 Exhibit 6.22: Forecast of North America (in USD Bn)
6.23 Exhibit 6.23: Forecast of United States (in USD Bn)
6.24 Exhibit 6.24: Forecast of Canada (in USD Bn)
6.25 Exhibit 6.25: Forecast of Rest of North America (in USD Bn)
6.26 Exhibit 6.26: Forecast of Europe (in USD Bn)
6.27 Exhibit 6.27: Forecast of United Kingdom (in USD Bn)
6.28 Exhibit 6.28: Forecast of Germany (in USD Bn)
6.29 Exhibit 6.29: Forecast of France (in USD Bn)
6.30 Exhibit 6.30: Forecast of Spain (in USD Bn)
6.31 Exhibit 6.31: Forecast of Italy (in USD Bn)
6.32 Exhibit 6.32: Forecast of Rest of Europe (in USD Bn)
6.33 Exhibit 6.33: Forecast of Asia Pacific (in USD Bn)
6.34 Exhibit 6.34: Forecast of China (in USD Bn)
6.35 Exhibit 6.35: Forecast of India (in USD Bn)
6.36 Exhibit 6.36: Forecast of Japan (in USD Bn)
6.37 Exhibit 6.37: Forecast of Singapore (in USD Bn)
6.38 Exhibit 6.38: Forecast of Australia (in USD Bn)
6.39 Exhibit 6.39: Forecast of Rest of Asia Pacific (in USD Bn)
6.40 Exhibit 6.40: Forecast of Latin America (in USD Bn)
6.41 Exhibit 6.41: Forecast of Brazil (in USD Bn)
6.42 Exhibit 6.42: Forecast of Argentina (in USD Bn)
6.43 Exhibit 6.43: Forecast of Rest of Latin America (in USD Bn)
6.44 Exhibit 6.44: Forecast of Middle East & Africa (in USD Bn)
6.45 Exhibit 6.45: Forecast of South Africa (in USD Bn)
6.46 Exhibit 6.46: Forecast of United Arab Emirates (in USD Bn)
6.47 Exhibit 6.47: Forecast of Rest of Middle East & Africa (in USD Bn)

Eurofins Scientific SE, SGS S.A., Intertek Group plc, Mérieux NutriSciences, Bureau Veritas, ALS Limited, TÜV SÜD, NSF International, Romer Labs, Microbac Laboratories

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Enterprise License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.